Commonwealth Coat of Arms of Australia

 

PB 105 of 2024

 

National Health (October 2024 Flow on price reductions for brands of combination items) (Exercise of Ministerial discretion) Determination 2024

I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following Determination.

Dated       26 September 2024

 

 

 

 

 

 

 

 

 

NIKOLAI TSYGANOV

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Health Resourcing Group

Department of Health and Aged Care

 

 

 

 

 

 

 

 

1  Name

 (1) This instrument is the National Health (October 2024 Flow on price reductions for brands of combination items) (Exercise of Ministerial discretion) Determination 2024. 

 (2) This instrument may also be cited as PB 105 of 2024.

2  Commencement

  This instrument commences 1 October 2024.

3  Authority

This instrument is made under subsection 99ADHB(6) of the Act.

4  Definition

 Note: A number of expressions used in this instrument are defined in Part VII the Act,

 

In this instrument:

 

 Act means the National Health Act 1953.

5  Brand of pharmaceutical item with approved ex-manufacturer price not reduced

I determine under subsection 99ADHB(6) of the Act that, for the purposes of subsection 99ADHB(2), the approved ex-manufacturer price, and each of the claimed prices (if applicable) of each brand of pharmaceutical item specified in column 2 in the table in Schedule 1 is not reduced on 1 October 2024.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 1 Brand of pharmaceutical item with approved ex-manufacturer price reduced not reduced

 

Column 1

Column 2

Item

Brand of Pharmaceutical Item

 

Drug

Form

Manner of administration

Brand

1

Tenofovir with emtricitabine and efavirenz

Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg and efavirenz 600 mg

Oral

Tenofovir Disoproxil Emtricitabine Efavirenz Viatris 300/200/600